AZN

AstraZeneca in partnering talks for Alzheimer’s drug

[Reuters – UK Focus] – * AstraZeneca (NYSE: AZN – news) ready to start Phase III tests on BACE drug (Adds quote, details on competitors, background) LONDON, May 7 (Reuters) – AstraZeneca, fighting a $106 billion bid approach from Pfizer (NYSE: PFE – news moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view […]

Pfizer Needs To Do More Over Takeover – PM

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

Is AstraZeneca’s Dividend Unbeatable?

moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

British PM: I want more commitments from Pfizer in potential AstraZeneca takeover

[Reuters – UK Focus] – British Prime Minister David Cameron said on Wednesday he wanted more commitments from Pfizer on its potential takeover of British pharmaceutical company AstraZeneca. The commitments that have been … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click here to view […]

British PM says wants assessment on Pfizer takeover bid for AstraZeneca

[Reuters – UK Focus] – British Prime Minister David Cameron said on Wednesday he wanted an assessment from ministers on U.S. drugmaker Pfizer (NYSE: PFE – news) ‘s takeover bid for British pharmaceutical company AstraZeneca (NYSE: AZN – news) . Cameron r moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who […]

AstraZeneca in partnering talks for Alzheimer drug

[Reuters – UK Focus] – AstraZeneca, fighting a $106 billion bid approach from Pfizer, is talking to other companies as it seeks a partnering deal for its experimental Alzheimer’s drug. Briggs Morrison, global head of medicines … moreView todays social media effects on AZNView the latest stocks trending across Twitter. Click to view dashboardSee who Astrazeneca is hiring next, click […]